ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in ESSA Pharma Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +13 vs. Q3 2024
- Shares held
- 32.8M
- −2.27M (−6.5%) vs. Q3 2024
- Total value
- $58.8M
- −$154.0M (−72.4%) vs. Q3 2024
- New holders
- 23
- 8 more added
- Sold out
- 10
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 8,748,629 | $15.7M | 0.53% | 00.0% | Unchanged |
| Tang Capital Management LLC | 4,300,000 | $7.70M | 0.51% | +4,300,000 | New |
| BML Capital Management, LLC | 4,221,546 | $7.56M | 4.69% | +4,221,546 | New |
| Morgan Stanley | 4,195,869 | $7.51M | 0.00% | +14,527+0.3% | Added |
| Soleus Capital Management, L.P. | 2,262,026 | $4.05M | 0.31% | −2,026,141−47.2% | Reduced |
| Opaleye Management Inc. | 2,209,998 | $3.96M | 0.69% | +2,209,998 | New |
| Pfizer Inc | 1,675,000 | $3.00M | 0.12% | +1,675,000 | New |
| Altium Capital Management LP | 1,428,000 | $2.56M | 0.80% | +1,428,000 | New |
| RTW Investments, LP | 1,113,002 | $1.99M | 0.03% | −2,148,494−65.9% | Reduced |
| Bank of America Corp | 812,310 | $1.45M | 0.00% | +812,302+10,153,775.0% | Added |
| Aldebaran Capital, LLC | 397,523 | $711.6K | 0.68% | +397,523 | New |
| Two Sigma Investments, LP | 211,204 | $378.1K | 0.00% | +211,204 | New |
| Marshall Wace, LLP | 181,217 | $324.4K | 0.00% | +181,217 | New |
| BNP Paribas Arbitrage, SA | 164,595 | $294.6K | 0.00% | +120,100+269.9% | Added |
| Citadel Advisors LLC | 159,041 | $284.7K | 0.00% | +130,562+458.5% | Added |
| UBS Group AG | 95,614 | $171.1K | 0.00% | +93,197+3,855.9% | Added |
| Two Sigma Advisers, LP | 82,600 | $147.9K | 0.00% | +82,600 | New |
| Magnus Financial Group LLC | 55,206 | $98.8K | 0.01% | +55,206 | New |
| Vazirani Asset Management LLC | 50,000 | $89.5K | 0.28% | +50,000 | New |
| Schonfeld Strategic Advisors LLC | 48,843 | $87.4K | 0.00% | −229,157−82.4% | Reduced |
| American Century Companies Inc | 46,373 | $83.0K | 0.00% | −279−0.6% | Reduced |
| Jane Street Group, LLC | 45,810 | $82.0K | 0.00% | +45,810 | New |
| XTX Topco Ltd | 37,526 | $67.2K | 0.01% | +37,526 | New |
| Group One Trading, L.P. | 36,348 | $65.1K | 0.00% | +8,553+30.8% | Added |
| Lepercq De Neuflize Asset Management LLC | 30,200 | $54.1K | 0.04% | +30,200 | New |
| Geode Capital Management, LLC | 26,858 | $48.1K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 26,287 | $47.1K | 0.00% | +26,287 | New |
| Prelude Capital Management, LLC | 25,000 | $44.8K | 0.00% | +25,000 | New |
| FNY Investment Advisers, LLC | 25,000 | $44.0K | 0.02% | +25,000 | New |
| Susquehanna International Group, LLP | 17,704 | $31.7K | 0.00% | +17,704 | New |
| GTS Securities LLC | 16,700 | $29.9K | 0.00% | +16,700 | New |
| Two Sigma Securities, LLC | 15,943 | $28.5K | 0.01% | +15,943 | New |
| Acadian Asset Management LLC | 15,687 | $28.0K | 0.00% | +15,687 | New |
| Squarepoint Ops LLC | 14,525 | $26.0K | 0.00% | +14,525 | New |
| 49 Wealth Management, LLC | 11,172 | $20.0K | 0.00% | +11,172 | New |
| BlackRock, Inc. | 7,074 | $12.7K | 0.00% | +1,465+26.1% | Added |
| Advisor Group Holdings, Inc. | 6,000 | $10.7K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,050 | $7.25K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 3,941 | $7.05K | 0.00% | +3,095+365.8% | Added |
| CIBC Private Wealth Group, LLC | 2,500 | $4.55K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 900 | $1.62K | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $1.07K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 918 | $1.00K | 0.00% | −39,879−97.7% | Reduced |
| Barclays PLC | 355 | $635 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 21 | $38 | 0.00% | 00.0% | Unchanged |
| Bellevue Group AG | 0 | $0 | 0.00% | −7,879,583−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −2,742,936−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,474,165−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −804,649−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −677,005−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −345,902−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −73,587−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −62,955−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −41,092−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,162−100.0% | Sold out |